Recurrence‐risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases

Abstract

The annual postoperative disease‐free survival for colorectal liver metastases can be easily estimated by weighting six preoperative clinical parameters (Beppu score). We identified three recurrence‐risk stratification groups: the low (≤6 points), moderate (7–10 points), and high‐risk (≥11 points). For low‐, moderate‐, and high‐risk patients, hepatectomy alone, hepatectomy with adjuvant chemotherapy, and hepatectomy with preoperative chemotherapy are recommended, respectively. The Beppu score enables the decision on the necessity and timing of perioperative chemotherapy.